Eva Veropalumbo

782 total citations
23 papers, 516 citations indexed

About

Eva Veropalumbo is a scholar working on Hematology, Biochemistry and Surgery. According to data from OpenAlex, Eva Veropalumbo has authored 23 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Biochemistry and 4 papers in Surgery. Recurrent topics in Eva Veropalumbo's work include Blood transfusion and management (6 papers), Hemostasis and retained surgical items (5 papers) and Hemophilia Treatment and Research (5 papers). Eva Veropalumbo is often cited by papers focused on Blood transfusion and management (6 papers), Hemostasis and retained surgical items (5 papers) and Hemophilia Treatment and Research (5 papers). Eva Veropalumbo collaborates with scholars based in Italy. Eva Veropalumbo's co-authors include Simonetta Pupella, Francesca Masiello, Ilaria Pati, Giuseppe Marano, Stefania Vaglio, Giancarlo M Liumbruno, Massimo Franchini, Mario Cruciani, Carlo Mengoli and Vanessa Piccinini and has published in prestigious journals such as Expert Opinion on Investigational Drugs, Infection and Annals of Translational Medicine.

In The Last Decade

Eva Veropalumbo

23 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Veropalumbo Italy 14 139 124 117 78 69 23 516
Andrew Cap United States 15 71 0.5× 133 1.1× 163 1.4× 27 0.3× 315 4.6× 28 608
Jung‐Sub An South Korea 15 99 0.7× 185 1.5× 80 0.7× 42 0.5× 67 1.0× 31 680
Trisha E. Wong United States 14 530 3.8× 28 0.2× 67 0.6× 457 5.9× 36 0.5× 27 851
Ricardo Rodrigues‐Pinto Portugal 17 21 0.2× 18 0.1× 498 4.3× 21 0.3× 12 0.2× 58 877
S. Brun France 13 6 0.0× 20 0.2× 125 1.1× 23 0.3× 26 0.4× 43 495
Dirk Buchwald Germany 17 245 1.8× 17 0.1× 193 1.6× 24 0.3× 69 1.0× 44 856
Duke O. Kasprisin United States 9 105 0.8× 46 0.4× 53 0.5× 57 0.7× 12 0.2× 18 464
Catherine Cox United States 11 46 0.3× 11 0.1× 135 1.2× 45 0.6× 3 0.0× 16 489
Peter Tesar Australia 17 44 0.3× 57 0.5× 529 4.5× 6 0.1× 67 1.0× 48 1.0k
Mark O. Hardin United States 11 63 0.5× 44 0.4× 250 2.1× 2 0.0× 327 4.7× 28 685

Countries citing papers authored by Eva Veropalumbo

Since Specialization
Citations

This map shows the geographic impact of Eva Veropalumbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Veropalumbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Veropalumbo more than expected).

Fields of papers citing papers by Eva Veropalumbo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Veropalumbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Veropalumbo. The network helps show where Eva Veropalumbo may publish in the future.

Co-authorship network of co-authors of Eva Veropalumbo

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Veropalumbo. A scholar is included among the top collaborators of Eva Veropalumbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Veropalumbo. Eva Veropalumbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Agostini, Vanessa, Francesca Masiello, Stefania Vaglio, et al.. (2025). A Survey on the implementation of Patient Blood Management programs in Italy.. PubMed. 23(3). 223–231. 1 indexed citations
2.
Masiello, Francesca, Ilaria Pati, Eva Veropalumbo, et al.. (2023). Ultrasound-guided injection of platelet-rich plasma for tendinopathies: a systematic review and meta-analysis.. PubMed. 21(2). 119–136. 27 indexed citations
3.
Piccinini, Vanessa, Giuseppe Marano, Liviana Catalano, et al.. (2022). Vasovagal reactions in whole blood and apheresis donors: a cross-sectional study on donor haemovigilance data from 2016 to 2019 in Italy.. PubMed. 20(4). 281–291. 7 indexed citations
4.
Pati, Ilaria, Claudio Velati, Carlo Mengoli, et al.. (2021). A forecasting model to estimate the drop in blood supplies during the SARS‐CoV‐2 pandemic in Italy. Transfusion Medicine. 31(3). 200–205. 1 indexed citations
5.
Franchini, Massimo, Giuseppe Marano, Mario Cruciani, et al.. (2020). COVID-19-associated coagulopathy. Diagnosis. 7(4). 357–363. 44 indexed citations
6.
Cruciani, Mario, Massimo Franchini, Carlo Mengoli, et al.. (2020). The use of whole blood in traumatic bleeding: a systematic review. Internal and Emergency Medicine. 16(1). 209–220. 14 indexed citations
7.
Franchini, Massimo, Giuseppe Marano, Ilaria Pati, et al.. (2020). Investigational drugs to treat hemophilia. Expert Opinion on Investigational Drugs. 29(3). 295–301. 9 indexed citations
8.
Franchini, Massimo, Giuseppe Marano, Eva Veropalumbo, et al.. (2019). Patient Blood Management: a revolutionary approach to transfusion medicine.. PubMed. 17(3). 191–195. 95 indexed citations
9.
Velati, Claudio, Luisa Romanò, Ilaria Pati, et al.. (2019). Prevalence, incidence and residual risk of transfusion-transmitted hepatitis B virus infection in Italy from 2009 to 2018.. PubMed. 17(6). 409–417. 24 indexed citations
10.
Franchini, Massimo, Mario Cruciani, Carlo Mengoli, et al.. (2019). The use of platelet-rich plasma in oral surgery: a systematic review and meta-analysis.. PubMed. 17(5). 357–367. 27 indexed citations
11.
Cruciani, Mario, Massimo Franchini, Carlo Mengoli, et al.. (2019). Platelet-rich plasma for sports-related muscle, tendon and ligament injuries: an umbrella review.. PubMed. 17(6). 465–478. 23 indexed citations
12.
Franchini, Massimo, Giuseppe Marano, Ilaria Pati, et al.. (2019). Emicizumab for the treatment of haemophilia A: a narrative review.. PubMed. 17(3). 223–228. 34 indexed citations
13.
Franchini, Massimo, Mario Cruciani, Carlo Mengoli, et al.. (2019). Serum eye drops for the treatment of ocular surface diseases: a systematic review and meta-analysis.. PubMed. 17(3). 200–209. 27 indexed citations
14.
Cicchetti, Americo, Silvia Coretti, Paolo Rebulla, et al.. (2018). Budget impact of implementing platelet pathogen reduction into the Italian blood transfusion system.. PubMed. 16(6). 483–489. 10 indexed citations
15.
Franchini, Massimo, Carlo Mengoli, Mario Cruciani, et al.. (2018). The use of viscoelastic haemostatic assays in non-cardiac surgical settings: a systematic review and meta-analysis.. PubMed. 16(3). 235–243. 17 indexed citations
16.
Franchini, Massimo, Giuseppe Marano, Simonetta Pupella, et al.. (2018). Rare congenital bleeding disorders. Annals of Translational Medicine. 6(17). 331–331. 20 indexed citations
17.
Franchini, Massimo, Giuseppe Marano, Simonetta Pupella, et al.. (2018). Management of mild hemophilia A. Expert Opinion on Orphan Drugs. 6(10). 585–591. 1 indexed citations
18.
Franchini, Massimo, Carlo Mengoli, Mario Cruciani, et al.. (2018). Safety and efficacy of tranexamic acid for prevention of obstetric haemorrhage: an updated systematic review and meta-analysis.. PubMed. 16(4). 329–337. 43 indexed citations
19.
Veropalumbo, Eva, Aldo Marrone, Giuseppe Perruolo, et al.. (2010). Immunocompromised Patients with HBsAg <i>a </i>Determinant Mutants: Comparison of HBsAg Diagnostic Assays. Intervirology. 53(3). 183–187. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Cap Breakdown of academic impact, for papers by Jung‐Sub An Breakdown of academic impact, for papers by Trisha E. Wong Breakdown of academic impact, for papers by Ricardo Rodrigues‐Pinto Breakdown of academic impact, for papers by S. Brun Breakdown of academic impact, for papers by Dirk Buchwald Breakdown of academic impact, for papers by Duke O. Kasprisin Breakdown of academic impact, for papers by Catherine Cox Breakdown of academic impact, for papers by Peter Tesar Breakdown of academic impact, for papers by Mark O. Hardin
Rankless by CCL
2026